AJO LP’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,023,418
Closed -$61.7M 319
2020
Q3
$61.7M Sell
1,023,418
-1,719,123
-63% -$103M 0.65% 46
2020
Q2
$161M Buy
2,742,541
+2,111,314
+334% +$126M 1.47% 6
2020
Q1
$35.2M Buy
631,227
+57,429
+10% +$3.51M 0.32% 99
2019
Q4
$36.8M Sell
573,798
-69,258
-11% -$3.97M 0.22% 120
2019
Q3
$32.6M Sell
643,056
-1,241,154
-66% -$58.3M 0.19% 133
2019
Q2
$85.4M Sell
1,884,210
-791,750
-30% -$36.9M 0.44% 78
2019
Q1
$128M Sell
2,675,960
-404,835
-13% -$20.2M 0.66% 47
2018
Q4
$160M Buy
3,080,795
+533,899
+21% +$28.7M 0.9% 32
2018
Q3
$158M Sell
2,546,896
-325,233
-11% -$19.3M 0.75% 37
2018
Q2
$159M Sell
2,872,129
-45,202
-2% -$2.44M 0.73% 39
2018
Q1
$185M Buy
2,917,331
+226,108
+8% +$14.5M 0.84% 33
2017
Q4
$165M Buy
2,691,223
+1,943,195
+260% +$122M 0.71% 43
2017
Q3
$47.7M Buy
748,028
+195,317
+35% +$11.4M 0.21% 127
2017
Q2
$30.8M Buy
+552,711
New +$30.1M 0.13% 152

Other funds holding BMY

AJO LP's BMY Position: Q4 2020 in Review

AJO LP sold out of Bristol-Myers Squibb (BMY) in Q4 2020, closing a stake of 1,023,418 shares — an estimated $61.7M sold.

AJO LP first reported a position in BMY in Q2 2017 and held it in 14 quarters. The position peaked at $185M in Q1 2018. 2,359 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

  • AJO LP reported no remaining Bristol-Myers Squibb position as of Q4 2020 after selling out during the quarter.
  • AJO LP sold 1,023,418 Bristol-Myers Squibb shares in Q4 2020, an estimated $61.7M.
  • AJO LP first reported a position in Bristol-Myers Squibb in Q2 2017 and held it in 14 quarters.
  • AJO LP's Bristol-Myers Squibb position peaked at $185M in Q1 2018.
  • 2,359 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on AJO LP's 13F filing for Q4 2020, filed 5 Feb 2021.